Correlation between cord blood apelin and IGF-1 levels in retinopathy of prematurity

Biomarkers in Medicine

Volumn 6, Issue 6, 2012, Pages 821-825

  Cekmez, Ferhat ^a   Pirgon, Ozgur ^a   Aydemir, Gokhan ^b   Dundar, Bumin ^a   Çekmez, Yasemin ^c   Karaoglu, Abdulbaki ^a   Fidanc, Kürsat ^a   Tunc, Turan ^a   Aydinoz, Secil ^a   Karademir, Ferhan ^a   Süleymanoglu, Selami ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b SULEYMAN DEMIREL UNIVERSITY   (Turkey)

^c Sami Ulus Hospital   (Turkey)

Author keywords

apelin; cytokine; insulin like growth factor 1; neonate; retinopathy of prematurity

Indexed keywords

APELIN; SOMATOMEDIN C;

ARTICLE; BIRTH WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE CLASSIFICATION; FEMALE; GESTATIONAL AGE; HUMAN; INFANT; MALE; PROTEIN BLOOD LEVEL; RETROLENTAL FIBROPLASIA; SMALL FOR DATE INFANT; TURKEY (REPUBLIC); UMBILICAL CORD BLOOD;

FEMALE; FETAL BLOOD; HUMANS; INFANT, NEWBORN; INSULIN-LIKE GROWTH FACTOR I; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; PREMATURE BIRTH; RETINOPATHY OF PREMATURITY;

EID: 84870864043     PISSN: 17520363     EISSN: 17520371     Source Type: Journal    
DOI: 10.2217/bmm.12.82     Document Type: Article

References (29)

1. Kinsey VE. Cooperative study of retrolental fibroplasia and the use of oxygen. Arch. Ophthalmol. 56, 481-543 (1956
2. Terry TL. Extreme prematurity and fibroblastic overgrowth of persistent vascular sheath behind each crystalline lens. Am. J. Ophthalmol. 25, 203-204 (1942
3. Hellström A, Engström E, Hård AL et al. Postnatal serum insulin-like growth factor I deficiency is associated with retinopathy of prematurity and other complications of premature birth. Pediatrics 112, 1016-1020 (2003
4. Lutty GA, Chan-Ling T, Phelps DL et al. Proceedings of the Third International Symposium on Retinopathy of Prematurity: An update on ROP from the lab to the nursery (November 2003, Anaheim, California). Mol. Vis. 12, 532-580 (2006
5. Fortes Filho JB, Bonomo PP, Maia M et al. Weight gain measured at 6 weeks after birth as a predictor for severe retinopathy of prematurity: Study with 317 very low birth weight preterm babies. Graefes Arch. Clin. Exp. Ophthalmol. 247, 831-836 (2009
6. Boucher J, Masri B, Daviaud D et al. Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology 146, 1764-1771 (2005
7. Kralisch S, Lossner U, Bluher M, Paschke R, Stumvoll M, Fasshauer M. Growth hormone induces apelin mRNA expression and secretion in mouse 3T3-L1 adipocytes. Regul. Pept. 139, 84-89 (2007
8. Carpéné C, Dray C, Attané C et al. Expanding role for the apelin/APJ system in physiopathology. J. Physiol. Biochem. 63, 359-373 (2007
9. Rayalam S, Della-Fera MA, Krieg PA, Cox CM, Robins A, Baile CA. Aputative role for apelin in the etiology of obesity. Biochem. Biophys. Res. Commun. 368, 815-819 (2008
10. Cox CM, D'Agostino SL, Miller MK, Heimark RL, Krieg PA. Apelin, the ligand for the endothelial G-protein-coupled receptor, APJ, is a potent angiogenic factor required for normal vascular development of the frog embryo. Dev. Biol. 296, 177-189 (2006
11. Committee for the Classification of Retinopathy of Prematurity. An international classification of retinopathy of prematurity. Arch. Ophthalmol. 102(8), 1130-1134 (1984
12. Davenport ML, Svoboda ME, Koerber KL et al. Plasma concentrations of insulin-like growth factor II (IGF-II) are not changed by short-Term fasting and refeeding. J. Clin. Endocrinol. Metab. 67, 1231-1236 (1988
13. Smith LE, Shen W, Perruzzi C et al. Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor. Nat. Med. 5, 1390-1395 (1999
14. Smith LE. Pathogenesis of retinopathy of prematurity. Semin. Neonatol. 8, 469-473 (2003
15. Kasai A, Shintani N, Oda M et al. Apelin is a novel angiogenic factor in retinal endothelial cells. Biochem. Biophys. Res. Commun. 325, 395-400 (2004
16. Cleaver O, Tonissen KF, Saha MS, Krieg PA. Neovascularization of the Xenopus embryo. Dev. Dyn. 210, 66-77 (1997
17. Tao Y, Lu Q, Jiang YR et al. Apelin in plasma and vitreous and in fibrovascular retinal membranes of patients with proliferative diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 51(8), 4237-4242 (2010
18. Qian J, Lu Q, Tao Y, Jiang YR. Vitreous and plasma concentrations of apelin and vascular endothelial growth factor after intravitreal bevacizumab in eyes with proliferative diabetic retinopathy. Retina 31(1), 161-168 (2011
19. Mataftsi A, Dimitrakos SA, Adams GG. Mediators involved in retinopathy of prematurity and emerging therapeutic targets. Early Hum. Dev. 87(10), 683-690 (2011
20. Hellstrom A, Perruzzi C, Ju M et al. Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: Direct correlation with clinical retinopathy of prematurity. Proc. Natl Acad. Sci. USA 98(10), 5804-5808 (2001
21. Smith LE, Kopchick JJ, Chen W et al. Essential role of growth hormone in ischemia-Induced retinal neovascularization. Science 276, 1706-1709 (1997
22. Lofqvist C, Andersson E, Sigurdsson J et al. Longitudinal postnatal weight and insulinlike growth factor I measurements in the prediction of retinopathy of prematurity. Arch. Ophthalmol. 124, 1711-1718 (2006
23. Hellström A, Hård AL, Engström E et al. Early weight gain predicts retinopathy in preterm infants: New, simple, efficient approach to screening. Pediatrics 123, 638-645 (2009
24. Lofqvist C, Andersson E, Sigurdsson J et al. Validation of a new retinopathy of prematurity screening method monitoring longitudinal postnatal weight and insulinlike growth factor I. Arch. Ophthalmol. 127, 622-627 (2009
25. Kasai A, Ishimaru Y, Kinjo T et al. Apelin is a crucial factor for hypoxia-Induced retinal angiogenesis. Arterioscler. Thromb. Vasc. Biol.30(11), 2182-2187 (2010
26. Cobellis L, De Falco M, Mastrogiacomo A et al. Modulation of apelin and APJ receptor in normal and preeclampsia-complicated placentas. Histol. Histopathol. 22, 1-8 (2007
27. Cekmez F, Pirgon O, Tanju IA et al. Cord plasma concentrations of visfatin, adiponectin and insulin in healthy term neonates: Positive correlation with birthweight. Int. J. Biomed. Sci. 5, 3 (2009
28. Meral C, Cekmez F, Pirgon O et al. The relationship between serum visfatin, adiponectin, and insulin sensitivity markers in neonates after birth. J. Matern. Fetal Neonatal Med. 24(1), 166-170 (2011
29. Cekmez F, Canpolat FE, Cetinkaya M et al. IGF-I and visfatin levels in retinopathy of prematurity. J. Pediatr. Ophthalmol. Strabismus 49(2), 120-124 (2012